GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

Locally Advanced Nasopharyngeal Carcinoma Clinical Trial

Official title:
A Multicenter, Randomized Controlled Phase III Clinical Trial of GP Induction Chemotherapy With TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Status Recruiting

Clinical Trial Summary

Through randomized controlled phase III multicenter clinical trials, GP induction chemotherapy vs TPF regimen adjuvant chemotherapy combined with DDP concurrent chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma: the efficacy, toxicity and quality of life, and further improvement Survival rate and improve the quality of life.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoma
Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms

Clinical Trial Details

NCT number	NCT03604965
Study type	Interventional
Source	Guiyang Medical University
Contact	Feng Jin, Bachelor
Phone	0851-86512802
Email	jinf8865@yeah.net
Status	Recruiting
Phase	Phase 3
Start date	July 21, 2018
Completion date	July 21, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05062005` - ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma	Phase 3
Completed	`NCT01462474` - Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma	Phase 1
Recruiting	`NCT03574324` - TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC	Phase 3
Recruiting	`NCT05860868` - Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma	Phase 3
Recruiting	`NCT05397769` - Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.	Phase 2
Not yet recruiting	`NCT04910347` - A Phase 2, Open-label Trial of Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma	Phase 2
Not yet recruiting	`NCT05892354` - Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy	N/A
Recruiting	`NCT03015727` - Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma	Phase 3
Recruiting	`NCT05503914` - Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma	N/A